Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Total Non-Current Liabilities: 2018-2025

Historic Total Non-Current Liabilities for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $298.0 million.

  • Dr Reddys Laboratories' Total Non-Current Liabilities rose 125.76% to $298.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $298.0 million, marking a year-over-year increase of 125.76%. This contributed to the annual value of $298.0 million for FY2025, which is 125.76% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Total Non-Current Liabilities stood at $298.0 million for FY2025, which was up 125.76% from $132.0 million recorded in FY2024.
  • In the past 5 years, Dr Reddys Laboratories' Total Non-Current Liabilities registered a high of $298.0 million during FY2025, and its lowest value of $61.0 million during FY2023.
  • Its 3-year average for Total Non-Current Liabilities is $163.7 million, with a median of $132.0 million in 2024.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 44.04% in 2023, then skyrocketed by 125.76% in 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Total Non-Current Liabilities (Yearly) stood at $124.0 million in 2021, then declined by 12.10% to $109.0 million in 2022, then slumped by 44.04% to $61.0 million in 2023, then skyrocketed by 116.39% to $132.0 million in 2024, then soared by 125.76% to $298.0 million in 2025.